相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells
Gang Xue et al.
CANCER CELL (2021)
ARC-9: Phase Ib/II study to evaluate etrumadenant (AB928)-based treatment combinations in patients with metastatic colorectal cancer (mCRC).
Michael Cecchini et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
CD39 Regulation and Functions in T Cells
Eleonora Timperi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong et al.
CANCER DISCOVERY (2020)
Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non-Small Cell Lung Cancer
Elena Ivanova et al.
CLINICAL CANCER RESEARCH (2020)
On the mechanism of anti-CD39 immune checkpoint therapy
David Allard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study
A. Agne et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
A phase I, open-label, multicenter study to assess the safety, pharmacokinetics, and preliminary antitumor activity of AZD4635 both as monotherapy and in combination in patients with advanced solid malignancies: Results from prostate cancer patients (NCT02740985).
Emerson A. Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cx43 channels and signaling via IP3/Ca2+, ATP, and ROS/NO propagate radiation-induced DNA damage to non-irradiated brain microvascular endothelial cells
Delphine Hoorelbeke et al.
CELL DEATH & DISEASE (2020)
Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
Laura Schaekel et al.
FRONTIERS IN PHARMACOLOGY (2020)
Revisiting the PD-1 pathway
Nikolaos Patsoukis et al.
SCIENCE ADVANCES (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy
Haojie Liu et al.
ACS NANO (2019)
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
Yang Liu et al.
NATURE COMMUNICATIONS (2019)
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Xian-Yang Li et al.
CANCER DISCOVERY (2019)
Design strategies for chemical-stimuli-responsive programmable nanotherapeutics
Muhammad Gulfam et al.
DRUG DISCOVERY TODAY (2019)
Boronic acids as building blocks for the construction of therapeutically useful bioconjugates
Joao P. M. Antonio et al.
CHEMICAL SOCIETY REVIEWS (2019)
Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect
Zhikuan Chen et al.
ACS NANO (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li et al.
CANCER RESEARCH (2018)
Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.
Alberto Chiappori et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into CheckpointResponsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Brian J. Christmas et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Current studies of immunotherapy in head and neck cancer
V. Dogan et al.
CLINICAL OTOLARYNGOLOGY (2018)
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells
Fernando P. Canale et al.
CANCER RESEARCH (2018)
Ectonucleotidase inhibitors: a patent review (2011-2016)
Mariya Al-Rashida et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Targeting immune checkpoints in breast cancer: an update of early results
Cinzia Solinas et al.
ESMO OPEN (2017)
Immunosuppressive cell death in cancer
Jiajie Hou et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Purinergic Signaling in the Cardiovascular System
Geoffrey Burnstock
CIRCULATION RESEARCH (2017)
Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery
Xin Liu et al.
ADVANCED MATERIALS (2016)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
Muhammad Baghdadi et al.
CANCER RESEARCH (2016)
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Immunosuppressive activities of adenosine in cancer
Bertrand Allard et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
10-Boronic acid substituted camptothecin as prodrug of SN-38
Lei Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers
Ellen C. Moore et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade
Ellen Moore et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Regulatory T Cells: Differentiation and Function
George Plitas et al.
CANCER IMMUNOLOGY RESEARCH (2016)
A Metabolic immune Checkpoint: Adenosine in Tumor Microenvironment
Akio Ohta
FRONTIERS IN IMMUNOLOGY (2016)
Purinergic regulation of the immune system
Caglar Cekic et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
Jeremy Bastid et al.
CANCER IMMUNOLOGY RESEARCH (2015)
A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy
Hiroko Miyabe et al.
JOURNAL OF CONTROLLED RELEASE (2014)
An Activatable Prodrug for the Treatment of Metastatic Tumors
Eun-Joong Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Regulation of inflammation by adenosine
Gyoergy Hasko et al.
FRONTIERS IN IMMUNOLOGY (2013)
ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness
Nancy P. Judd et al.
CANCER RESEARCH (2012)
Comparative Analysis of Tumor-Infiltrating Lymphocytes in a Syngeneic Mouse Model of Oral Cancer
Nancy P. Judd et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Haeusler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Laetitia Aymeric et al.
CANCER RESEARCH (2010)
Crystal Structure of a Legionella pneumophila Ecto-Triphosphate Diphosphohydrolase, A Structural and Functional Homolog of the Eukaryotic NTPDases
Julian P. Vivian et al.
STRUCTURE (2010)
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Michael R. Elliott et al.
NATURE (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Hydrolysis of extracellular ATP and immune suppression: humans versus mice
Stefania Gorini et al.
BLOOD (2008)
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Michail V. Sitkovsky et al.
CLINICAL CANCER RESEARCH (2008)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD39/NTPDase-1 activity and expression in normal leukocytes
E. Dianne Pulte et al.
THROMBOSIS RESEARCH (2007)
ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors
Yu Chen et al.
SCIENCE (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function
V Brinkmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
分享论文
